热门资讯> 正文

PTC Therapeutics报告第二季度业绩

2024-08-09 04:24

PTC治疗(PTCT) 0
普拉格能源(PLUG) 0

PTC Therapeutics press release (NASDAQ:PTCT): Q2 Revenue of $187M (-12.5% Y/Y) beats by $5.99M.
Net loss was $99.2 million for the second quarter of 2024, compared to net loss of $198.9 million for the second quarter of 2023.
Cash, cash equivalents, and marketable securities were $1,093.3 million on June 30, 2024, compared to $876.7 million on December 31, 2023.

More on PTC Therapeutics

PTC Therapeutics: Riding The Regulatory Rollercoaster With Translarna
PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts
PTC Therapeutics Q2 2024 Earnings Preview
Biggest stock movers today: PLUG, NKE, DJT, and more
Seeking Alpha’s Quant Rating on PTC Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。